Guijin He

1 article listing Guijin He in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Neoadjuvant ARX788 plus pyrotinib versus trastuzumab, pertuzumab, docetaxel and carboplatin for HER2-positive breast cancer: a randomised phase 2b trial Nature Communications